In a 50‑year‑old woman with type‑2 diabetes who underwent retrograde intrarenal surgery and double‑J stent placement for a renal calculus and now has refractory postoperative shock with persistent fever despite broad‑spectrum antimicrobial therapy (ceftazidime‑avibactam, aztreonam, fosfomycin, caspofungin, teicoplanin), what is the most urgent next step in management?

Urgent Percutaneous Nephrostomy (PCN) Placement with Immediate Blood and Urine Cultures

This patient requires emergency percutaneous nephrostomy (PCN) placement as the most urgent next step, along with immediate blood and urine cultures before any antimicrobial changes. Despite broad-spectrum coverage and a functioning DJ stent, the refractory shock and persistent fever indicate inadequate source control, likely pyonephrosis or obstructed infected system that the internal stent cannot adequately drain. 1, 2

Why PCN is Superior to Continued Medical Management

PCN provides larger-bore drainage that is critical in pyonephrosis and septic shock, where internal stents may be insufficient. 1 The ACR guidelines specifically state that PCN is the preferred option "in a setting such as pyonephrosis, when larger tube decompression may be warranted" and that PCN "has been shown to improve early and long-term cure rates compared to ureteral stent in cases of infection." 1, 2

• In septic patients with obstructed infected systems, retrograde ureteral catheters (DJ stents) carry a higher risk of persistent urosepsis compared with PCN, particularly when there is extrinsic obstruction or heavy bacterial load. 1
• The ACR explicitly recommends PCN for "patients at high risk for anesthesia, or in a setting such as pyonephrosis." 1
• PCN should be performed emergently in hemodynamically unstable or septic patients, even before imaging if necessary, to achieve rapid source control. 2

Critical Diagnostic Steps Before Changing Antibiotics

Obtain blood cultures (minimum two sets) and urine cultures immediately before any antimicrobial modification to identify the causative pathogen and guide definitive therapy. 2 The Surviving Sepsis Campaign guidelines emphasize obtaining cultures before starting or changing antibiotics when temperature ≥38°C with systemic signs of infection. 1

• This patient is already on extremely broad coverage (ceftazidime-avibactam, aztreonam, fosfomycin, caspofungin, teicoplanin), suggesting either inadequate source control, resistant organisms, or non-bacterial etiology. 1
• Changing antibiotics without cultures compromises diagnostic accuracy and may miss resistant organisms or fungal pathogens. 3

Imaging to Guide Intervention

Perform contrast-enhanced CT urogram immediately to assess stent position, patency, degree of hydronephrosis, perinephric collections, and any complications such as perforation or malposition. 2 This is the gold standard for detecting complications in non-pregnant patients with fever and leukocytosis despite stenting. 2

• Do not postpone imaging when clinical status worsens; prompt CT is required to identify correctable anatomic causes. 2
• CT may reveal stent malposition, severe persistent hydronephrosis, perinephric abscess, or pyonephrosis—all indications for urgent PCN. 2

Why the Current Antimicrobial Regimen May Be Failing

Inadequate Source Control is the Primary Issue

Persistent fever and shock despite maximal antibiotics strongly suggests inadequate drainage rather than antimicrobial resistance alone. 1 The World Journal of Emergency Surgery guidelines state that "an ineffective or inadequate antimicrobial regimen is one of the variables more strongly associated with unfavorable outcomes in critically ill patients," but emphasize that source control must be adequate first. 1

Consider Metallo-Beta-Lactamase (MBL) Producers

• The combination of ceftazidime-avibactam resistance with aztreonam coverage suggests possible MBL-producing organisms (e.g., NDM-producing Enterobacteriaceae). 4
• If MBL is suspected based on culture results, the combination of ceftazidime-avibactam plus aztreonam plus colistin has shown efficacy in case reports of carbapenemase-producing organisms. 4
• However, this patient is already on ceftazidime-avibactam and aztreonam, yet remains in shock—reinforcing that source control is the issue. 4

Fungal Sepsis Must Be Considered

The Surviving Sepsis Campaign guidelines identify this patient's risk factors for invasive Candida: diabetes mellitus, recent major surgery, prolonged broad-spectrum antibiotics, and invasive devices (DJ stent). 1

• Caspofungin is appropriate empiric coverage for Candida in this critically ill patient with septic shock. 1
• Echinocandins (caspofungin) are preferred in severe illness and septic shock over triazoles. 1

Post-PCN Management

Antimicrobial Adjustment

• After PCN placement and culture results, tailor antimicrobial therapy to sensitivities and continue monitoring until temperature, WBC, and inflammatory markers normalize. 2
• If cultures grow MBL-producing organisms, continue the triple combination of ceftazidime-avibactam, aztreonam, and colistin. 4
• If cultures remain negative or show typical uropathogens, consider de-escalation once source control is achieved. 1

Monitoring for Complications

• Postprocedural bacteremia and sepsis are common when infected urinary tracts are drained, so maintain intensive monitoring immediately post-PCN. 2
• Continuous infusion ceftazidime-avibactam may optimize PK/PD targets in critically ill renal patients and minimize microbiological failure. 5

Common Pitfalls to Avoid

• Do not delay PCN placement while attempting further antimicrobial escalation—inadequate drainage is the likely cause of refractory shock. 1, 2
• Do not assume the DJ stent is providing adequate drainage—internal stents may fail in pyonephrosis or heavy bacterial loads. 1, 2
• Do not change antibiotics before obtaining cultures—this compromises diagnostic accuracy in an already complex case. 2, 3
• Do not overlook fungal sepsis—this diabetic patient with prolonged antibiotics and invasive devices is at high risk. 1

Summary Algorithm

1. Immediate blood and urine cultures (before any antimicrobial changes) 2, 3
2. Urgent contrast-enhanced CT urogram to assess stent function and identify collections 2
3. Emergency PCN placement for superior drainage in septic shock with obstructed infected system 1, 2
4. Continue current broad-spectrum antimicrobials (including caspofungin for fungal coverage) until culture results available 1
5. Tailor therapy based on cultures and sensitivities, considering MBL-producers if resistant patterns emerge 4
6. Monitor closely post-PCN for resolution of fever, shock, and inflammatory markers 2